Please provide your email address to receive an email when new articles are posted on . The AGA formulated 11 conditional recommendations to inform the use of biomarkers in the management of Crohn’s ...
This prospective study in a large cohort of patients examined the use of calprotectin measurement in feces as a diagnostic test to identify clinically significant gastrointestinal findings in patients ...
New AGA clinical practice guidelines highlight the role of noninvasive biomarkers, including fecal calprotectin, fecal lactoferrin and C-reactive protein, for the management of patients with ...
Table 1. Studies assessing the usefulness of different ELISA tests for fecal calprotectin and correspondent cutoff points.
Although not currently recommended as a formal therapeutic target in ulcerative colitis (UC) management, histologic healing is associated with improved long-term clinical outcomes. In a small ...
Share on Pinterest Blood tests could be used more in the future in Crohn’s disease management. Bisual Studio/Stocksy More than half a million people in the United States live with Crohn’s disease. New ...
Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent ...
I am still haunted by my initiation to Crohn disease. My late brother Andrew, who succumbed to the illness because of a confluence of complications at 29 years-old, first manifested symptoms as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results